Roche Holding Valuation

RHHVF Stock  USD 252.40  2.20  0.88%   
At this time, the company appears to be overvalued. Roche Holding AG holds a recent Real Value of $206.97 per share. The prevailing price of the company is $252.4. Our model determines the value of Roche Holding AG from analyzing the company fundamentals such as Return On Equity of 0.45, shares outstanding of 693.89 M, and Operating Margin of 0.32 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support locking in undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
252.40
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding AG is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Roche Holding AG is useful when determining the fair value of the Roche otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Roche Holding. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche OTC Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  252.4 Real  206.97 Hype  252.4 Naive  241.5
The real value of Roche OTC Stock, also known as its intrinsic value, is the underlying worth of Roche Holding AG OTC Stock, which is reflected in its stock price. It is based on Roche Holding's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roche Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
205.36
Downside
206.97
Real Value
277.64
Upside
Estimating the potential upside or downside of Roche Holding AG helps investors to forecast how Roche otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
249.47251.85254.24
Details
Hype
Prediction
LowEstimatedHigh
250.79252.40254.01
Details
Naive
Forecast
LowNext ValueHigh
239.90241.50243.11
Details

Roche Holding Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roche Holding competition to find correlations between indicators driving Roche Holding's intrinsic value. More Info.
Roche Holding AG is currently regarded as top stock in net asset category among related companies. It is currently regarded as top stock in five year return category among related companies . The ratio of Net Asset to Five Year Return for Roche Holding AG is about  28,581,114,551 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Roche Holding by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Roche Holding's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Roche Holding's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Roche Holding's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Roche Holding and how it compares across the competition.

About Roche Holding Valuation

The otc valuation mechanism determines the current worth of Roche Holding AG on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Roche Holding AG. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Roche Holding AG based exclusively on its fundamental and basic technical indicators. By analyzing Roche Holding's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Roche Holding's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Roche Holding. We calculate exposure to Roche Holding's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Roche Holding's related companies.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Hld operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.

8 Steps to conduct Roche Holding's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Roche Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Roche Holding's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Roche Holding's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Roche Holding's revenue streams: Identify Roche Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Roche Holding's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Roche Holding's growth potential: Evaluate Roche Holding's management, business model, and growth potential.
  • Determine Roche Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Roche Holding's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Roche Holding Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Roche Holding does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding854.3 M
Quarterly Earnings Growth Y O Y-0.326
Forward Price Earnings14.1243
Retained Earnings34.2 B
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roche Holding AG. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Roche OTC Stock analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Please note, there is a significant difference between Roche Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if Roche Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roche Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.